ACTIVE-SITE LABELING WITH DANSYL-GLUTAMYL-GLYCYL-ARGINYL CHLOROMETHYL KETONE DEMONSTCATES THE FULL ACTIVITY OF THE REFOLDED AND PURIFIED TISSUE-TYPE PLASMINOGEN-ACTIVATOR VARIANT BM-06.022

被引:2
作者
KOHNERT, U
WOZNY, M
LLINAS, M
ROOS, A
FISCHER, S
机构
[1] Boehringer Mannheim GmbH, Biochemical Research Center Penzberg, Penzberg, D-82377
关键词
T-PA; VARIANT; ESCHERICHIA-COLI; REFOLDING; ACTIVE SITE LABELING;
D O I
10.1007/BF02783556
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BM 06.022 is a tissue-type plasminogen activator deletion variant that is comprised of the kringle 2 and the protease domain of the native molecule. BM 06.022 is expressed as inactive inclusion bodies in E. coli and transferred into the active enzyme by an in vitro folding process. Active site labeling with dansyl-glutamyl-glycyl-arginyl chloromethyl ketone provides evidence that the purified BM 06.022 is fully active and that misfolded species are completely removed by affinity chromatography on ETI-Sepharose. The comparison of the kinetics of the inhibition of BM 06.022 with that of CHO-t-PA indicates that the active centers of both enzymes are rather similar. The further evaluation of the site of interaction of BM 06.022 and DnsEGRck by mass spectroscopy and amino acid sequence analysis revealed that the inhibitor is bound selectively to His(322), which is part of the catalytic triad of this serine protease.
引用
收藏
页码:157 / 166
页数:10
相关论文
共 14 条
[1]  
BINDER BR, 1979, J BIOL CHEM, V254, P1998
[2]   X-RAY DIFFRACTION STUDIES OF ENZYMES [J].
BLOW, DM ;
STEITZ, TA .
ANNUAL REVIEW OF BIOCHEMISTRY, 1970, 39 :63-+
[3]   THE INCORPORATION OF A FLUORESCENT-PROBE INTO THE ACTIVE-SITES OF ONE-CHAIN AND 2-CHAIN TISSUE-TYPE PLASMINOGEN-ACTIVATOR [J].
HIGGINS, DL ;
LAMB, MC .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1986, 249 (02) :418-426
[4]  
KITZ R, 1962, J BIOL CHEM, V237, P3245
[5]   BIOCHEMICAL-PROPERTIES OF THE KRINGLE 2 AND PROTEASE DOMAINS ARE MAINTAINED IN THE REFOLDED T-PA DELETION VARIANT BM 06.022 [J].
KOHNERT, U ;
RUDOLPH, R ;
VERHEIJEN, JH ;
WEENINGVERHOEFF, EJD ;
STERN, A ;
OPITZ, U ;
MARTIN, U ;
LILL, H ;
PRINZ, H ;
LECHNER, M ;
KRESSE, GB ;
BUCKEL, P ;
FISCHER, S .
PROTEIN ENGINEERING, 1992, 5 (01) :93-100
[6]   HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR - PRODUCTION IN CONTINUOUS SERUM-FREE CELL-CULTURE AND RAPID PURIFICATION [J].
KRUITHOF, EKO ;
SCHLEUNING, WD ;
BACHMANN, F .
BIOCHEMICAL JOURNAL, 1985, 226 (03) :631-636
[7]  
MACARTNEY HW, 1989, Patent No. 302503
[8]  
MULLER M, 1992, FIBRINOLYSIS S2, V6, P26
[9]  
NEUHAUS KL, 1991, CIRCULATION S4, V84
[10]   CLONING AND EXPRESSION OF HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR CDNA IN ESCHERICHIA-COLI [J].
PENNICA, D ;
HOLMES, WE ;
KOHR, WJ ;
HARKINS, RN ;
VEHAR, GA ;
WARD, CA ;
BENNETT, WF ;
YELVERTON, E ;
SEEBURG, PH ;
HEYNEKER, HL ;
GOEDDEL, DV ;
COLLEN, D .
NATURE, 1983, 301 (5897) :214-221